Literature DB >> 9660357

Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection.

D Bourboulia, D Whitby, C Boshoff, R Newton, V Beral, H Carrara, A Lane, F Sitas.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9660357     DOI： 10.1001/jama.280.1.31-a

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  25 in total

1.  2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

Authors: 
Journal:  Infect Dis Obstet Gynecol       Date:  2002

Review 2.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Authors:  Kristen Stolka; Paul Ndom; Jennifer Hemingway-Foday; Jeniffer Iriondo-Perez; Wendell Miley; Nazzarena Labo; Jennifer Stella; Mahamat Abassora; Godfrey Woelk; Robin Ryder; Denise Whitby; Jennifer S Smith
Journal:  Cancer Epidemiol       Date:  2014-03-13       Impact factor: 2.984

Review 4.  A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

Authors:  Dorothy E Dow; Coleen K Cunningham; Ann M Buchanan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-09-04       Impact factor: 3.164

5.  Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt".

Authors:  Sheila C Dollard; Lisa M Butler; Alison M Graves Jones; Jonathan H Mermin; Midion Chidzonga; Tsungai Chipato; Caroline H Shiboski; Christian Brander; Anisa Mosam; Photini Kiepiela; Wolfgang Hladik; Jeffrey N Martin
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

6.  New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies.

Authors:  N Inoue; E C Mar; S C Dollard; C P Pau; Q Zheng; P E Pellett
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Mortality among HIV-1- and human herpesvirus type 8-affected mother-infant pairs in Zambia.

Authors:  Janet Wojcicki; Mulindi Mwanahamuntu; Veenu Minhas; Boris Djokic; Chipepo Kankasa; Winslow Klaskala; Brad Brayfield; Saul Phiri; Charles Wood; Charles D Mitchell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

8.  Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Authors:  Lisa M Butler; Grant Dorsey; Wolfgang Hladik; Philip J Rosenthal; Christian Brander; Torsten B Neilands; Georgina Mbisa; Denise Whitby; Photini Kiepiela; Anisa Mosam; Similo Mzolo; Sheila C Dollard; Jeffrey N Martin
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

9.  Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.

Authors:  Joseph H Jeong; Rebecca Hines-Boykin; John D Ash; Dirk P Dittmer
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 10.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.